Drug name - Altabax
| Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These patents protects the active chemical substance. Only patent owner can launch products that use this active substance. | ||||
| US7875630 | ALMIRALL | Process salts compositions and use |
Feb, 2027
(4 years from now) | |
| EP1663220A4 | ALMIRALL | Novel Process, Salts, Compositions And Use |
Aug, 2024
(1 year, 10 months from now) | |
| EP1663220A1 | ALMIRALL | Novel Process For The Preparation Of Pleuromutilin Derivatives |
Aug, 2024
(1 year, 10 months from now) | |
| EP1663220B1 | ALMIRALL | Novel Process For The Preparation Of Pleuromutilin Derivatives |
Aug, 2024
(1 year, 10 months from now) | |
| These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US8207191 | ALMIRALL | Process, salts, composition and use |
Aug, 2024
(1 year, 10 months from now) | |
Drugs and Companies using RETAPAMULIN ingredient
Treatment: Treatment of impetigo due to staphylococcus aureus or streptococcus pyogenes
Dosage: OINTMENT;TOPICAL
More Information on Dosage
| Strength | Dosage | Availability |
|---|---|---|
| 1% | OINTMENT;TOPICAL | Prescription |
availability in other generic markets.
Click on the highlighted region to filter.